{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:52:31Z","timestamp":1781650351940,"version":"3.54.5"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009169","name":"Assiut University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009169","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gentamicin (GS) is a potent aminoglycoside antibiotic whose clinical use is limited by nephrotoxicity associated with oxidative stress, mitochondrial dysfunction, and inflammation. This study aimed to explore the renoprotective mechanisms of resmetirom (RES) and curcumin (CUR) against GS-induced renal injury in rats, emphasizing anti-inflammatory and mitochondrial pathways and supporting findings through molecular docking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Twenty-four adult male Wistar rats were randomly allocated into four groups (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096): control, GS (100\u2009mg\/kg, i.p.), GS\u2009+\u2009CUR (200\u2009mg\/kg, oral), and GS\u2009+\u2009RES (3\u2009mg\/kg, oral). Treatments were administered for seven days. Serum renal biomarkers (urea, creatinine) and tissue oxidative stress markers (MDA, NO, GSH) were quantified using spectrophotometric methods. Specific kidney damage indicators for kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) were evaluated. Gene expressions of dynamin-related protein 1 (DRP1) and AKT Serine\/Threonine Kinase 1 (AKT1) were analyzed by quantitative RT-PCR, while mammalian target of rapamycin (mTOR) and forkhead box protein O1 (FOXO1) protein expression were assessed immunohistochemically. Histopathological and ultrastructural evaluations were conducted using light and electron microscopy. Molecular docking was performed using AutoDock Vina to assess binding affinities of CUR and RES with AKT1, DRP1, FOXO1, and mTOR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>GS administration significantly elevated serum urea and creatinine and increased renal MDA levels while decreasing NO and GSH. These alterations were markedly attenuated by CUR and RES, with RES showing superior improvement in renal function and oxidative balance. qPCR analysis revealed significant GS-induced upregulation of AKT1 and DRP1, which was normalized by both CUR and RES. Immunohistochemistry demonstrated downregulation of mTOR and FOXO1 following GS exposure, with substantial restoration after CUR and RES treatments. Histopathological and ultrastructural analyses confirmed the protective effects of both compounds, showing preserved glomerular and tubular integrity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Resmetirom and CUR showed significant renoprotective benefits against GS-induced nephrotoxicity by alleviating oxidative stress, modulating mitochondrial dynamics, and restoring cellular signaling pathways involving AKT1, DRP1, mTOR, and FOXO1. The molecular docking results corroborate their direct interactions with these targets, highlighting RES as a promising therapeutic agent for nephroprotection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-04928-8","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:25:02Z","timestamp":1776101102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In vivo and molecular docking investigation of the novel anti-inflammatory and mitochondrial mechanisms underlying the renoprotective effects of resmetirom and curcumin in gentamicin-induced renal toxicity in rats"],"prefix":"10.1186","volume":"27","author":[{"given":"Amira S.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud S.","family":"Sabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman S.","family":"Shaltout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab S.","family":"Abdelqader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"4928_CR1","doi-asserted-by":"publisher","first-page":"110838","DOI":"10.1016\/j.cbi.2023.110838","volume":"388","author":"A D\u017eidi\u0107-Krivi\u0107","year":"2024","unstructured":"D\u017eidi\u0107-Krivi\u0107 A, Sher EK, Kusturica J, Farhat EK, Nawaz A, Sher F. Unveiling drug induced nephrotoxicity using novel biomarkers and cutting-edge preventive strategies. Chemico-Biol Interact. 2024;388:110838.","journal-title":"Chemico-Biol Interact"},{"issue":"11","key":"4928_CR2","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.ekir.2023.08.031","volume":"8","author":"RE Campbell","year":"2023","unstructured":"Campbell RE, Chen CH, Edelstein CL. Overview of antibiotic-induced nephrotoxicity. Kidney Int Rep. 2023;8(11):2211\u201325.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"4928_CR3","doi-asserted-by":"publisher","first-page":"20158","DOI":"10.1038\/s41598-025-05385-3","volume":"15","author":"MS Sabra","year":"2025","unstructured":"Sabra MS, Allam EA, Darwish MH, Abdelhafez EA, Hassan AS, Ahmed AA, et al. A novel nanoparticle glutathione and lepidium sativum treatment for gentamicin-induced acute renal failure in rats. Sci Rep. 2025;15(1):20158.","journal-title":"Sci Rep"},{"issue":"4","key":"4928_CR4","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.4103\/1319-2442.338285","volume":"32","author":"SM Chuah","year":"2021","unstructured":"Chuah SM, Lim AB, Ooi JQ, Osman NA, Ho PY, Loh JS, et al. Nephrotoxic medications and risk factors of acute kidney injury in Medical wards: a single-center study. Saudi J Kidney Dis Transplant. 2021;32(4):1118\u201327.","journal-title":"Saudi J Kidney Dis Transplant"},{"issue":"15","key":"4928_CR5","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.3390\/molecules28155781","volume":"28","author":"M Adaszy\u0144ska-Skwirzy\u0144ska","year":"2023","unstructured":"Adaszy\u0144ska-Skwirzy\u0144ska M, Zych S, Buc\u0142aw M, Majewska D, Dzi\u0119cio\u0142 M, Szczerbi\u0144ska D. Evaluation of the antibacterial activity of gentamicin in combination with essential oils isolated from different cultivars and morphological parts of lavender (Lavandula angustifolia Mill.) against selected bacterial strains. Molecules. 2023;28(15):5781.","journal-title":"Molecules"},{"issue":"2","key":"4928_CR6","first-page":"11","volume":"3","author":"MA Gamaan","year":"2023","unstructured":"Gamaan MA, Zaky HS, Ahmed HI. Gentamicin-induced nephrotoxicity: a mechanistic approach. Azhar Int J Pharm Med Sci. 2023;3(2):11\u201319.","journal-title":"Azhar Int J Pharm Med Sci"},{"issue":"1","key":"4928_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.toxlet.2013.01.024","volume":"219","author":"Y-C Li","year":"2013","unstructured":"Li Y-C, Shih Y-M, Lee J-A. Gentamicin caused renal injury deeply related to methylglyoxal and N\u025b-(carboxyethyl) lysine (CEL). Toxicol Lett. 2013;219(1):85\u201392.","journal-title":"Toxicol Lett"},{"issue":"1","key":"4928_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/metabo13010049","volume":"13","author":"AM Tom\u015fa","year":"2022","unstructured":"Tom\u015fa AM, R\u0103chi\u015fan AL, Pandrea SL, Benea A, Uif\u0103lean A, Toma C, et al. Curcumin and vitamin C attenuate gentamicin-induced nephrotoxicity by modulating distinctive reactive species. Metabolites. 2022;13(1):49.","journal-title":"Metabolites"},{"key":"4928_CR9","doi-asserted-by":"crossref","unstructured":"Boima V, Agyekum AB, Ganatra K, Agyekum F, Kwakyi E, Inusah J, et al. Advances in kidney disease: pathogenesis and therapeutic targets. Front Med. 2025;12:1526090.","DOI":"10.3389\/fmed.2025.1526090"},{"key":"4928_CR10","doi-asserted-by":"crossref","unstructured":"Singh A, Singh L, Dalal D. Formononetin as a multifaceted modulator of renal pathology: insights into fibrotic, oxidative, inflammatory, and apoptotic pathways. Pharmacological Rep. 2025;1\u201315.","DOI":"10.1007\/s43440-025-00801-x"},{"key":"4928_CR11","doi-asserted-by":"crossref","unstructured":"Zhang M, Zhou Y, Wang X, Li Y, Wu Xa. Gentamicin aggravates renal injury by affecting mitochondrial dynamics, altering renal transporters expression, and exacerbating apoptosis. Toxicol Lett. 2025.","DOI":"10.1016\/j.toxlet.2025.07.1418"},{"key":"4928_CR12","doi-asserted-by":"crossref","unstructured":"Korkut Celikates B, Ilgin S, Yilmaz MU, Atli Eklioglu O. Targeting the powerhouse: the mitochondrial perspective on gentamicin-induced kidney injury. Archives Toxicol. 2026.","DOI":"10.1007\/s00204-026-04310-5"},{"key":"4928_CR13","doi-asserted-by":"publisher","first-page":"154306","DOI":"10.1016\/j.phymed.2022.154306","volume":"104","author":"Y Cai","year":"2022","unstructured":"Cai Y, Huang C, Zhou M, Xu S, Xie Y, Gao S, et al. Role of curcumin in the treatment of acute kidney injury: research challenges and opportunities. Phytomedicine. 2022;104:154306.","journal-title":"Phytomedicine"},{"issue":"7","key":"4928_CR14","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3390\/molecules24071393","volume":"24","author":"AWK Yeung","year":"2019","unstructured":"Yeung AWK, Horba\u0144czuk M, Tzvetkov NT, Mocan A, Carradori S, Maggi F, et al. Curcumin: total-scale analysis of the scientific literature. Molecules. 2019;24(7):1393.","journal-title":"Molecules"},{"key":"4928_CR15","doi-asserted-by":"crossref","unstructured":"Wang L, Wu N, Zhang W, Huang D, Li Y. Curcumin alleviates sepsis-associated acute kidney injury potentially by inhibiting ferroptosis through the ACSL4\/GPX4 signaling pathway. Drug Dev Res. 2025;86(7):e70181.","DOI":"10.1002\/ddr.70181"},{"issue":"1","key":"4928_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.17925\/EE.2023.19.1.60","volume":"19","author":"G Karim","year":"2023","unstructured":"Karim G, Bansal MB. Resmetirom: an orally administered, smallmolecule, liver-directed, \u03b2-selective THR agonist for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. touchREVIEWS Endocrinol. 2023;19(1):60.","journal-title":"touchREVIEWS Endocrinol"},{"key":"4928_CR17","doi-asserted-by":"crossref","unstructured":"Shakeel L, Shaukat A, Akilimali A. Resmetirom: a breakthrough in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD). Health Sci Rep. 2025;8(6):e70920.","DOI":"10.1002\/hsr2.70920"},{"issue":"1","key":"4928_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.apsb.2024.07.025","volume":"15","author":"K Wang","year":"2025","unstructured":"Wang K, Chen F, Wang J, Liu H. Drug discovery targeting thyroid hormone receptor \u03b2 (THR\u03b2) for the treatment of liver diseases and other medical indications. Acta Pharmaceutica Sin. B. 2025;15(1):35\u201351.","journal-title":"Acta Pharmaceutica Sin. B"},{"key":"4928_CR19","doi-asserted-by":"crossref","unstructured":"Al-Worafi YM. Evidence-Based Complementary, Alternative, and integrated Medicine and efficacy and safety: concepts. In: Handbook of complementary, alternative, and integrative medicine. CRC Press; 2025. p. 1\u201313.","DOI":"10.1201\/9781003328117-1"},{"key":"4928_CR20","doi-asserted-by":"crossref","unstructured":"Copur S, Yavuz F, Kanbay M. Thyroid hormone beta receptor agonists for treatment of kidney disease: a promising agent? Eur J Clin Investigation. 2023;53(5):e13939.","DOI":"10.1111\/eci.13939"},{"issue":"7","key":"4928_CR21","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/antiox13070754","volume":"13","author":"MM Quetglas-Llabr\u00e9s","year":"2024","unstructured":"Quetglas-Llabr\u00e9s MM, Monserrat-Mesquida M, Bouzas C, Garc\u00eda S, Mateos D, Casares M, et al. Effects of a two-year lifestyle intervention on intrahepatic Fat reduction and renal Health: mitigation of inflammation and oxidative stress, a randomized trial. Antioxidants. 2024;13(7):754.","journal-title":"Antioxidants"},{"key":"4928_CR22","doi-asserted-by":"crossref","unstructured":"Shyam M, Pal A, Dey D, Sharma V, Wadhwa J, Srirangan P, et al. Natural compounds as nephroprotective agents: therapeutic potential against drug-induced kidney injury. J Educ Chang Biochemical Mol Toxicol. 2025;39(12):e70649.","DOI":"10.1002\/jbt.70649"},{"issue":"2","key":"4928_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.etp.2009.03.006","volume":"62","author":"\u0130 Yaman","year":"2010","unstructured":"Yaman \u0130, Balikci E. Protective effects of Nigella sativa against gentamicin-induced nephrotoxicity in rats. Exp Toxicologic Pathol. 2010;62(2):183\u201390.","journal-title":"Exp Toxicologic Pathol"},{"key":"4928_CR24","doi-asserted-by":"crossref","unstructured":"Haryuna TSH, Fauziah D, Anggraini S, Harahap MPH, Harahap J. Antioxidant effect of curcumin on the prevention of oxidative damage to the cochlea in an ototoxic rat model based on malondialdehyde expression. Int Archives Otorhinolaryngology. 2022;26(1):e119\u201324.","DOI":"10.1055\/s-0040-1722161"},{"key":"4928_CR25","doi-asserted-by":"publisher","first-page":"1127517","DOI":"10.3389\/fonc.2023.1127517","volume":"13","author":"A Caddeo","year":"2023","unstructured":"Caddeo A, Serra M, Sedda F, Bacci A, Manera C, Rapposelli S, et al. Potential use of TG68-A novel thyromimetic-for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis. Front Oncol. 2023;13:1127517.","journal-title":"Front Oncol"},{"issue":"1","key":"4928_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.15171\/jrip.2017.10","volume":"6","author":"M Rahimi-Madiseh","year":"2016","unstructured":"Rahimi-Madiseh M, Naimi A, Heydarian E, Rafieian-Kopaei M. Renal biochemical and histopathological alterations of diabetic rats under treatment with hydro alcoholic morus nigra extrac. J Retailing Renal Inj Prev. 2016;6(1):56.","journal-title":"J Retailing Renal Inj Prev"},{"key":"4928_CR27","doi-asserted-by":"publisher","first-page":"177306","DOI":"10.1016\/j.ejphar.2025.177306","volume":"991","author":"MM El Tabaa","year":"2025","unstructured":"El Tabaa MM, Faheem H, Elballal MS, Rashad E, Mohsen M, El Tabaa MM. The PPAR-\u03b1 agonist oleoyethanolamide (OEA) ameliorates valproic acid-induced steatohepatitis in rats via suppressing Wnt3a\/\u03b2-catenin and activating PGC-1\u03b1: involvement of network pharmacology and molecular docking. Eur J Pharmacol. 2025;991:177306.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"4928_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361.","journal-title":"J Comput Chem"},{"key":"4928_CR29","doi-asserted-by":"publisher","first-page":"117793222211256","DOI":"10.1177\/11779322221125605","volume":"16","author":"EM Terefe","year":"2022","unstructured":"Terefe EM, Ghosh A. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of phytochemicals isolated from Croton dichogamus against the HIV-1 reverse transcriptase. Bioinform Biol Insights. 2022;16:11779322221125605.","journal-title":"Bioinform Biol Insights"},{"issue":"9","key":"4928_CR30","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3390\/foods12091779","volume":"12","author":"AA Shamsol","year":"2023","unstructured":"Shamsol AA, Tan JJ, Abdullah MNH, Bahari H, Lim V, Yong YK. Network pharmacology and molecular docking analysis of active compounds in tualang honey against atherosclerosis. Foods. 2023;12(9):1779.","journal-title":"Foods"},{"issue":"10","key":"4928_CR31","doi-asserted-by":"publisher","first-page":"7865","DOI":"10.1007\/s00210-024-03128-1","volume":"397","author":"MS Sabra","year":"2024","unstructured":"Sabra MS, Allam EA, Hassanein KMA. Sildenafil and furosemide nanoparticles as a novel pharmacological treatment for acute renal failure in rats. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2024;397(10):7865\u201379.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"1","key":"4928_CR32","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00210-024-03303-4","volume":"398","author":"MS Sabra","year":"2025","unstructured":"Sabra MS, Allam EA, El-Aal MA, Hassan NH, Mostafa A-HM, Ahmed AA. A novel pharmacological strategy using nanoparticles with glutathione and virgin coconut oil to treat gentamicin-induced acute renal failure in rats. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2025;398(1):933\u201350.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"4","key":"4928_CR33","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s12010-024-05141-9","volume":"197","author":"N Maghraby","year":"2025","unstructured":"Maghraby N, El-Baz MA, Hassan AM, Abd-Elghaffar SK, Ahmed AS, Sabra MS. Metformin alleviates doxorubicin-induced cardiotoxicity via preserving mitochondrial dynamics balance and calcium homeostasis. Appl Biochem Biotechnol. 2025;197(4):2713\u201333.","journal-title":"Appl Biochem Biotechnol"},{"key":"4928_CR34","doi-asserted-by":"crossref","unstructured":"Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harb Protoc. 2008;2008(5):db. prot 4986.","DOI":"10.1101\/pdb.prot4986"},{"issue":"24","key":"4928_CR35","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1038\/emboj.2010.268","volume":"29","author":"W Fan","year":"2010","unstructured":"Fan W, Morinaga H, Kim JJ, Bae E, Spann NJ, Heinz S, et al. FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages. Embo J. 2010;29(24):4223\u201336.","journal-title":"Embo J"},{"key":"4928_CR36","doi-asserted-by":"crossref","unstructured":"Sun H, Shao X, He J, Golos M, Shi B. Role of the mTOR-FOXO1 pathway in obesity-associated renal tubulointerstitial inflammation. Mol Med Rep. 2019;19(2):1284\u201393.","DOI":"10.3892\/mmr.2018.9727"},{"key":"4928_CR37","doi-asserted-by":"crossref","unstructured":"Wan X, Xing Z, Ouyang J, Liu H, Cheng C, Luo T, et al. Histomorphological and ultrastructural cadmium-induced kidney injuries and precancerous lesions in rats and screening for biomarkers. Biosci Rep. 2022;42(6):BSR20212516.","DOI":"10.1042\/BSR20212516"},{"key":"4928_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jot.2024.08.010","volume":"49","author":"C Cheng","year":"2024","unstructured":"Cheng C, Deng M, Cheng C, Wu H, Wang Y, Lu M, et al. FOXO1-mTOR pathway in vascular pericyte regulates the formation of type H vessels to control bone metabolism. J Orthopaedic Transl. 2024;49:246\u201363.","journal-title":"J Orthopaedic Transl"},{"issue":"2\u20133","key":"4928_CR39","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ejphar.2011.08.037","volume":"670","author":"R Manikandan","year":"2011","unstructured":"Manikandan R, Beulaja M, Thiagarajan R, Priyadarsini A, Saravanan R, Arumugam M. Ameliorative effects of curcumin against renal injuries mediated by inducible nitric oxide synthase and nuclear factor kappa B during gentamicin-induced toxicity in Wistar rats. Eur J Pharmacol. 2011;670(2\u20133):578\u201385.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"4928_CR40","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/jphp.12534","volume":"68","author":"SA Abuelezz","year":"2016","unstructured":"Abuelezz SA, Hendawy N, Abdel Gawad S. Alleviation of renal mitochondrial dysfunction and apoptosis underlies the protective effect of sitagliptin in gentamicin-induced nephrotoxicity. The J Pharm Pharmacol. 2016;68(4):523\u201332.","journal-title":"The J Pharm Pharmacol"},{"issue":"1","key":"4928_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s44337-025-00315-8","volume":"2","author":"W Bwambale","year":"2025","unstructured":"Bwambale W, Oka VO, Onaadepo O, Etukudo EM, Owu DU, Nkanu EE, et al. Advancing nephroprotective strategies: the role of naringenin in preventing gentamicin-induced nephrotoxicity. Discover Med. 2025;2(1):115.","journal-title":"Discover Med"},{"key":"4928_CR42","doi-asserted-by":"publisher","first-page":"1218506","DOI":"10.3389\/fphar.2023.1218506","volume":"14","author":"S Gumbar","year":"2023","unstructured":"Gumbar S, Bhardwaj S, Mehan S, Khan Z, Narula AS, Kalfin R, et al. Renal mitochondrial restoration by gymnemic acid in gentamicin-mediated experimental nephrotoxicity: evidence from serum, kidney and histopathological alterations. Front Pharmacol. 2023;14:1218506.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4928_CR43","first-page":"604","volume":"5","author":"M Akhlaq","year":"2026","unstructured":"Akhlaq M, Maaz H, Masih Z, Shah SQ, Waleed M, Alum MK, et al. Green Extraction of nephroprotective phytochemicals for chronic kidney disease: a pharmacognostic and pharmacological review. Pak J Med & Cardiological Rev. 2026;5(1):604\u201321.","journal-title":"Pak J Med & Cardiological Rev"},{"key":"4928_CR44","doi-asserted-by":"publisher","first-page":"115921","DOI":"10.1016\/j.fct.2025.115921","volume":"209","author":"F Hayati","year":"2026","unstructured":"Hayati F, Ghoflchi S, Sadeghi A, Kesharwani P, Sahebkar A, Hosseini H. Synthetic curcumin analogs in nephrotoxicity: mechanisms and therapeutic advances. Food Chem Toxicol. 2026;209:115921.","journal-title":"Food Chem Toxicol"},{"key":"4928_CR45","doi-asserted-by":"crossref","unstructured":"Lee MC, Cheng KJ, Chen SM, Li YC, Imai K, Lee CM, et al. A novel preventive mechanism of gentamicin-induced nephrotoxicity by atorvastatin. Biomed Chromatogr: BMC. 2019;33(11):e 4639.","DOI":"10.1002\/bmc.4639"},{"issue":"1","key":"4928_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5527\/wjn.v4.i1.57","volume":"4","author":"S Lopez-Giacoman","year":"2015","unstructured":"Lopez-Giacoman S, Madero M. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol. 2015;4(1):57.","journal-title":"World J Nephrol"},{"issue":"9","key":"4928_CR47","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/antiox9090821","volume":"9","author":"JC Jado","year":"2020","unstructured":"Jado JC, Humanes B, Gonz\u00e1lez-Nicol\u00e1s M\u00c1, Cama\u00f1o S, Lara JM, L\u00f3pez B, et al. Nephroprotective effect of cilastatin against gentamicin-induced renal injury in vitro and in vivo without altering its bactericidal efficiency. Antioxidants. 2020;9(9):821.","journal-title":"Antioxidants"},{"key":"4928_CR48","doi-asserted-by":"publisher","first-page":"820806","DOI":"10.3389\/fphar.2022.820806","volume":"13","author":"S Fuloria","year":"2022","unstructured":"Fuloria S, Mehta J, Chandel A, Sekar M, Rani NNIM, Begum MY, et al. A comprehensive review on the therapeutic potential of curcuma longa Linn. In relation to its major active constituent curcumin. Front Pharmacol. 2022;13:820806.","journal-title":"Front Pharmacol"},{"key":"4928_CR49","doi-asserted-by":"crossref","unstructured":"Peng Y, Ao M, Dong B, Jiang Y, Yu L, Chen Z, et al. Anti-inflammatory effects of curcumin in the inflammatory diseases: status, limitations and countermeasures. Drug Des Devel Ther. 2021;4503\u201325.","DOI":"10.2147\/DDDT.S327378"},{"key":"4928_CR50","doi-asserted-by":"crossref","unstructured":"Mert H, Cibuk S, Yildirim S, Mert N. The effect of protocatechuic acid on nephrotoxicity induced by gentamicin in rats. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2025.","DOI":"10.21203\/rs.3.rs-5341389\/v1"},{"issue":"1","key":"4928_CR51","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/13880209.2022.2037663","volume":"60","author":"P Laorodphun","year":"2022","unstructured":"Laorodphun P, Cherngwelling R, Panya A, Arjinajarn P. Curcumin protects rats against gentamicin-induced nephrotoxicity by amelioration of oxidative stress, endoplasmic reticulum stress and apoptosis. Pharm Biol. 2022;60(1):491\u2013500.","journal-title":"Pharm Biol"},{"issue":"11","key":"4928_CR52","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/antiox13111389","volume":"13","author":"A Sharma","year":"2024","unstructured":"Sharma A, Lee H-J. A review on the protecting effects and molecular mechanisms of berries against a silent Public Health concern: non-alcoholic fatty liver disease. Antioxidants. 2024;13(11):1389.","journal-title":"Antioxidants"},{"issue":"20","key":"4928_CR53","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.3390\/ijms20205238","volume":"20","author":"DM Tanase","year":"2019","unstructured":"Tanase DM, Gosav EM, Radu S, Costea CF, Ciocoiu M, Carauleanu A, et al. The predictive role of the biomarker kidney molecule-1 (KIM-1) in acute kidney injury (AKI) cisplatin-induced nephrotoxicity. Int J Mol Sci. 2019;20(20):5238.","journal-title":"Int J Mol Sci"},{"key":"4928_CR54","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.toxrep.2018.11.015","volume":"6","author":"V Udupa","year":"2019","unstructured":"Udupa V, Prakash V. Gentamicin induced acute renal damage and its evaluation using urinary biomarkers in rats. Toxicol Rep. 2019;6:91\u201399.","journal-title":"Toxicol Rep"},{"key":"4928_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.fct.2018.02.007","volume":"114","author":"KS Kim","year":"2018","unstructured":"Kim KS, Lim H-J, Lim JS, Son JY, Lee J, Lee BM, et al. Curcumin ameliorates cadmium-induced nephrotoxicity in Sprague-Dawley rats. Food Chem Toxicol. 2018;114:34\u201340.","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"4928_CR56","first-page":"376","volume":"22","author":"H Ghasemi","year":"2019","unstructured":"Ghasemi H, Einollahi B, Kheiripour N, Hosseini-Zijoud SR, Farhadian Nezhad M. Protective effects of curcumin on diabetic nephropathy via attenuation of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) expression and alleviation of oxidative stress in rats with type 1 diabetes. Iran J Basic Med Sci. 2019;22(4):376\u201383.","journal-title":"Iran J Basic Med Sci"},{"key":"4928_CR57","doi-asserted-by":"crossref","unstructured":"He L, Peng X, Zhu J, Liu G, Chen X, Tang C, et al. Protective effects of curcumin on acute gentamicin-induced nephrotoxicity in rats. Can J Physiol Pharmacol. 2015;93(4):275\u201382.","DOI":"10.1139\/cjpp-2014-0459"},{"issue":"13","key":"4928_CR58","doi-asserted-by":"publisher","first-page":"20988","DOI":"10.18632\/oncotarget.15470","volume":"8","author":"C Zhao","year":"2017","unstructured":"Zhao C, Chen Z, Qi J, Duan S, Huang Z, Zhang C, et al. Drp1-dependent mitophagy protects against cisplatin-induced apoptosis of renal tubular epithelial cells by improving mitochondrial function. Oncotarget. 2017;8(13):20988.","journal-title":"Oncotarget"},{"key":"4928_CR59","doi-asserted-by":"crossref","unstructured":"Cho S-G, Du Q, Huang S, Dong Z. Drp1 dephosphorylation in ATP depletion-induced mitochondrial injury and tubular cell apoptosis. Am J Physiol-Renal Physiol. 2010;299(1):F199\u2013206.","DOI":"10.1152\/ajprenal.00716.2009"},{"issue":"1","key":"4928_CR60","first-page":"917435","volume":"2015","author":"M Negrette-Guzm\u00e1n","year":"2015","unstructured":"Negrette-Guzm\u00e1n M, Garc\u00eda-Ni\u00f1o WR, Tapia E, Zazueta C, Huerta-Yepez S, Le\u00f3n-Contreras JC, et al. Curcumin attenuates gentamicin-induced kidney mitochondrial alterations: possible role of a mitochondrial biogenesis mechanism. Evidence-Based Complementary Alternative Med. 2015;2015(1):917435.","journal-title":"Evidence-Based Complementary Alternative Med"},{"key":"4928_CR61","doi-asserted-by":"crossref","unstructured":"Zou Z, Cheng X, Chen J, Xing C, Zhang C, Guo X, et al. Curcumin alleviates atrazine-induced nephrotoxicity by enhancing mitophagy through PINK1\/Parkin signaling pathway in mice. Ecotox Environ Safe. 2025;295:118118.","DOI":"10.1016\/j.ecoenv.2025.118118"},{"key":"4928_CR62","doi-asserted-by":"crossref","unstructured":"Hou D, Liao H, Hao S, Liu R, Huang H, Duan C. Curcumin simultaneously improves mitochondrial dynamics and myocardial cell bioenergy after sepsis via the SIRT1-DRP1\/PGC-1\u03b1 pathway. Heliyon. 2024;10(7).","DOI":"10.1016\/j.heliyon.2024.e28501"},{"issue":"1","key":"4928_CR63","doi-asserted-by":"publisher","first-page":"19790","DOI":"10.1038\/s41598-024-70242-8","volume":"14","author":"R Suvarna","year":"2024","unstructured":"Suvarna R, Shetty S, Pappachan JM. Efficacy and safety of Resmetirom, a selective thyroid hormone receptor-\u03b2 agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis. Sci Rep. 2024;14(1):19790.","journal-title":"Sci Rep"},{"issue":"3","key":"4928_CR64","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3390\/ijms25031518","volume":"25","author":"L-Y Chang","year":"2024","unstructured":"Chang L-Y, Chao Y-L, Chiu C-C, Chen P-L, Lin HY-H. Mitochondrial signaling, the mechanisms of AKI-to-CKD transition and potential treatment targets. Int J Mol Sci. 2024;25(3):1518.","journal-title":"Int J Mol Sci"},{"key":"4928_CR65","volume-title":"Mechanistic role of mitochondrial AKT1 in acute kidney injury","author":"Y-H Lin","year":"2019","unstructured":"Lin Y-H. Mechanistic role of mitochondrial AKT1 in acute kidney injury. UC Irvine; 2019."},{"issue":"1","key":"4928_CR66","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s40200-025-01563-2","volume":"24","author":"M Aliyari","year":"2025","unstructured":"Aliyari M, Ghoflchi S, Hashemy SI, Hashemi SF, Reihani A, Hosseini H. The PI3K\/Akt pathway: a target for curcumin\u2019s therapeutic effects. J Diabetes Metabolic Disord. 2025;24(1):52.","journal-title":"J Diabetes Metabolic Disord"},{"issue":"6","key":"4928_CR67","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/biof.1313","volume":"42","author":"E Molina-Jij\u00f3n","year":"2016","unstructured":"Molina-Jij\u00f3n E, Aparicio-Trejo OE, Rodr\u00edguez-Mu\u00f1oz R, Le\u00f3n-Contreras JC, Del Carmen C\u00e1rdenas-Aguayo M, Medina-Campos ON, et al. The nephroprotection exerted by curcumin in maleate-induced renal damage is associated with decreased mitochondrial fission and autophagy. BioFactors. 2016;42(6):686\u2013702.","journal-title":"BioFactors"},{"issue":"2","key":"4928_CR68","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/biof.1338","volume":"43","author":"OE Aparicio-Trejo","year":"2017","unstructured":"Aparicio-Trejo OE, Tapia E, Molina-Jij\u00f3n E, Medina-Campos ON, Mac\u00edas-Ruvalcaba NA, Le\u00f3n-Contreras JC, et al. Curcumin prevents mitochondrial dynamics disturbances in early 5\/6 nephrectomy: relation to oxidative stress and mitochondrial bioenergetics. Biofactors. 2017;43(2):293\u2013310.","journal-title":"Biofactors"},{"key":"4928_CR69","unstructured":"Garcia CJ. Mitochondrial uncouplers: development as therapeutics for metabolic diseases. 2021."},{"key":"4928_CR70","first-page":"3941","volume-title":"Mitochondrial dysfunction in MASLD: unveiling mechanisms and optimizing therapeutic strategies","author":"T Radosavljevi\u0107","year":"2025","unstructured":"Radosavljevi\u0107 T. Mitochondrial dysfunction in MASLD: unveiling mechanisms and optimizing therapeutic strategies. Bentham Science Publishers; 2025. p. 3941\u201344."},{"issue":"6","key":"4928_CR71","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.nefroe.2016.12.001","volume":"36","author":"BA Aldahmash","year":"2016","unstructured":"Aldahmash BA, El-Nagar DM, Ibrahim KE. Reno-protective effects of propolis on gentamicin-induced acute renal toxicity in Swiss albino mice. Nefrolog\u00eda (Engl Ed). 2016;36(6):643\u201352.","journal-title":"Nefrolog\u00eda (Engl Ed)"},{"issue":"8","key":"4928_CR72","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/ndt\/15.8.1175","volume":"15","author":"A Erdem","year":"2000","unstructured":"Erdem A, G\u00fcndogan N\u00dc, Usub\u00fct\u00fcn A, K\u0131l\u0131n\u00e7 K, Erdem \u015eR, Kara A, et al. The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats. Nephrol Dial Transpl. 2000;15(8):1175\u201382.","journal-title":"Nephrol Dial Transpl"},{"key":"4928_CR73","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1590\/S0100-879X2006000600016","volume":"39","author":"RA Volpini","year":"2006","unstructured":"Volpini RA, Balbi A, Costa RS, Coimbra TM. Increased expression of p38 mitogen-activated protein kinase is related to the acute renal lesions induced by gentamicin. Braz J Med Biol Res. 2006;39:817\u201323.","journal-title":"Braz J Med Biol Res"},{"key":"4928_CR74","first-page":"388","volume":"16","author":"P Randjelovic","year":"2017","unstructured":"Randjelovic P, Veljkovic S, Stojiljkovic N, Sokolovic D, Ilic I. Gentamicin nephrotoxicity in animals: current knowledge and future perspectives. Excli J. 2017;16:388.","journal-title":"Excli J"},{"key":"4928_CR75","unstructured":"Soliman KM, Abdul-Hamid M, Othman AI. Effect of carnosine on gentamicin-induced nephrotoxicity. Med Sci Monit. 2007;13(3):BR73\u201383."},{"issue":"4","key":"4928_CR76","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1472-8206.2005.00343.x","volume":"19","author":"B Ali","year":"2005","unstructured":"Ali B, Al-Wabel N, Mahmoud O, Mousa H, Hashad M. Curcumin has a palliative action on gentamicin-induced nephrotoxicity in rats. Fundam Clin Pharmacol. 2005;19(4):473\u201377.","journal-title":"Fundam Clin Pharmacol"},{"key":"4928_CR77","doi-asserted-by":"crossref","unstructured":"Narayanan Venkatesan NV, Durairaj Punithavathi DP, Venkatesan Arumugam VA. Curcumin prevents adriamycin nephrotoxicity in rats. 2000.","DOI":"10.1038\/sj.bjp.0703067"},{"issue":"1","key":"4928_CR78","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1054\/ceca.2001.0259","volume":"31","author":"J Dyer","year":"2002","unstructured":"Dyer J, Khan SZ, Bilmen J, Hawtin S, Wheatley M, Michelangeli F. Curcumin: a new cell-permeant inhibitor of the inositol 1, 4, 5-trisphosphate receptor. Cell Calcium. 2002;31(1):45\u201352.","journal-title":"Cell Calcium"},{"key":"4928_CR79","doi-asserted-by":"crossref","unstructured":"Mayadevi M, Sherin D, Keerthi V, Rajasekharan K, Omkumar R. Curcumin is an inhibitor of calcium\/calmodulin dependent protein kinase II. Bioorg Med Chem. 2012;20(20):6040\u201347.","DOI":"10.1016\/j.bmc.2012.08.029"},{"issue":"1","key":"4928_CR80","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41580-023-00649-0","volume":"25","author":"MJ Rodriguez-Colman","year":"2024","unstructured":"Rodriguez-Colman MJ, Dansen TB, Burgering BM. FOXO transcription factors as mediators of stress adaptation. Nat Rev Mater Mol Cell Biol. 2024;25(1):46\u201364.","journal-title":"Nat Rev Mater Mol Cell Biol"},{"issue":"6","key":"4928_CR81","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960\u201376.","journal-title":"Cell"},{"key":"4928_CR82","doi-asserted-by":"crossref","unstructured":"Zhao Y, Wei J, Hou X, Liu H, Guo F, Zhou Y, et al. SIRT1 rs10823108 and FOXO1 rs17446614 responsible for genetic susceptibility to diabetic nephropathy. Sci Rep. 2017;7(1):10285.","DOI":"10.1038\/s41598-017-10612-7"},{"issue":"11","key":"4928_CR83","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.34067\/KID.0003782020","volume":"1","author":"Y Gui","year":"2020","unstructured":"Gui Y, Dai C. mTOR signaling in kidney diseases. Kidney360. 2020;1(11):1319\u201327.","journal-title":"Kidney360"},{"issue":"3","key":"4928_CR84","doi-asserted-by":"publisher","first-page":"38963","DOI":"10.31083\/FBS38963","volume":"17","author":"R Kandel","year":"2025","unstructured":"Kandel R, Roy P, Singh KP. Molecular basis of oxidative stress-induced acute kidney injury, kidney fibrosis, chronic kidney disease: and clinical significance of targeting reactive oxygen species-regulated pathways to treat of kidney disease. Front Biosci-Scholar. 2025;17(3):38963.","journal-title":"Front Biosci-Scholar"},{"issue":"6","key":"4928_CR85","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","volume":"89","author":"M Nagata","year":"2016","unstructured":"Nagata M. Podocyte injury and its consequences. Kidney Int. 2016;89(6):1221\u201330.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04928-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04928-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04928-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:58:04Z","timestamp":1781647084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04928-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4928"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04928-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During each technique, we complied with the relevant ARRIVE recommendations and the U.K. Animals (Scientific Procedures) Act 1986 together with its associated regulations. The Faculty of Veterinary Medicine at Assiut University has sanctioned the experimental technique in accordance with the Institutional Animal Care & Use Committee (IACUC) (permission number: 06\/2025\/362).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"241"}}